Measles virus derivatives boon for prostate cancerJanuary 22nd, 2009 - 12:20 pm ICT by IANS
Washington, Jan 22 (IANS) Certain measles virus vaccine strain derivatives can effectively infect and kill prostate cancer cells.Prostate cancer is the second most common cause of cancer-related deaths among American men with an estimated 186,320 new cases and 28,660 deaths in 2008.
A sizeable proportion of these patients ultimately relapse, with a five-year failure rate for treatment ranging from 14 to 34 percent. No curative therapy is currently available for locally advanced or metastatic prostate cancer.
The median survival time of mice treated with a virus derivative MV-CEA in the study almost doubled compared to the controls, and complete tumour regression was observed in a fifth of the treated animals.
“Based on our preclinical results as well as the safety of measles derivatives in clinical trials against other tumour types, these viral strains could represent excellent candidates for clinical testing against advanced prostate cancer, including androgen resistant tumours,” said Evanthia Galanis, Mayo Clinic, senior author of the study.
The measles vaccine strains also have an excellent safety record with millions of vaccine doses having been safely administered in over 40 years of use, said a Mayo clinic release.
The new study appeared in The Prostate.
- Measles virus may offer prostate cancer treatment - Jan 22, 2009
- Potent anticancer drug isolated from weed - Jul 10, 2012
- Super vaccine could knock out 70 percent of cancers - Dec 13, 2011
- Discovery on measles could spur less toxic cancer cure - Nov 06, 2011
- Modified measles virus may help treat childhood brain tumours - May 27, 2010
- Twin viruses linked to prostate cancer - Aug 03, 2012
- Surgery effective for aggressive prostate cancer patients - Sep 28, 2010
- Measles virus is 'the latest weapon against cancer' - Jan 13, 2011
- New therapy shows promising result for HER2-positive metastatic disease - Oct 09, 2010
- Beehive extract may arrest prostate cancer - May 06, 2012
- Hormone therapy 'doubles survival chances in men with prostate cancer' - Mar 25, 2011
- Chicken vaccines mutate into new virus - Jul 16, 2012
- Statins can cut prostate cancer risk - Oct 02, 2011
- Molecule discovery good news for prostate cancer sufferers - Dec 29, 2009
- How to manipulate 'TRAP' gene for treating cancer - Dec 30, 2009
Tags: american men, curative therapy, failure rate, mayo clinic, measles vaccine, median survival, metastatic prostate cancer, preclinical results, prostate cancer, prostate cancer cells, safety record, second most common cause, sizeable proportion, survival time, tumour types, vaccine doses, vaccine strain, vaccine strains, viral strains, virus vaccine